Compare · AYLA vs CLX
AYLA vs CLX
Side-by-side comparison of Ayala Pharmaceuticals Inc. (AYLA) and Clorox Company (CLX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AYLA and CLX operate in Specialty Chemicals (Consumer Discretionary), so they compete in similar markets.
- CLX is the larger of the two at $11.71B, about 155.9x AYLA ($75.1M).
- CLX has hit the wire 4 times in the past 4 weeks while AYLA has been quiet.
- CLX has more recent analyst coverage (25 ratings vs 5 for AYLA).
- Company
- Ayala Pharmaceuticals Inc.
- Clorox Company
- Price
- $0.56+11.00%
- $96.78-1.50%
- Market cap
- $75.1M
- $11.71B
- 1M return
- -
- +5.18%
- 1Y return
- -
- -21.82%
- Industry
- Specialty Chemicals
- Specialty Chemicals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 0
- 4
- Recent ratings
- 5
- 25
Ayala Pharmaceuticals Inc.
Ayala Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, which is an intravenous injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma for patients bearing Notch-activating mutations. It is also involved in developing AL102, an oral injectable small molecule GSI that is in Phase I clinical trial for the treatment of desmoid tumors. Ayala Pharmaceuticals, Inc. has a collaboration agreement with Novartis International Pharmaceutical Limited to develop AL102 for the treatment of multiple myeloma. The company was incorporated in 2017 and is headquartered in Rehovot, Israel.
Clorox Company
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brand names; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brand names; professional food service products under the Hidden Valley brand name; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brand names in the United States. The Household segment provides cat litter products under the Fresh Step, Scoop Away, and Ever Clean brand names; bags and wraps under the Glad brand name; and grilling products under the Kingsford and Kingsford Match Light brand names in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand name; natural personal care products under the Burt's Bees brand name; and water-filtration systems and filters under the Brita brand name in the United States. The International segment provides laundry additives; home care products; water-filtration systems and filters; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brand names. The Clorox Company sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, third-party and owned e-commerce channels, military stores, and distributors, as well as a direct sales force. The company was founded in 1913 and is headquartered in Oakland, California.
Latest AYLA
- SEC Form 3 filed by new insider Martell Bridget A
- SEC Form 3 filed by new insider Orbach Pini
- SEC Form 3 filed by new insider Golan Roy
- SEC Form 10-K filed by Ayala Pharmaceuticals Inc.
- SEC Form SC 13G/A filed by Ayala Pharmaceuticals Inc. (Amendment)
- SEC Form SC 13G filed by Ayala Pharmaceuticals Inc.
- SEC Form SC 13G/A filed by Ayala Pharmaceuticals Inc. (Amendment)
- SEC Form 15-12G filed by Ayala Pharmaceuticals Inc.
- Ayala Pharmaceuticals Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets
- SEC Form 4: Amoon Growth Fund Limited Partnership returned 2,991,473 shares to the company
Latest CLX
- Clorox Healthcare Introduces Two Breakthrough Innovations to Help Solve Infection Prevention Challenges
- SEC Form SD filed by Clorox Company
- Clorox Company filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Clorox Board of Directors to Initiate Comprehensive CEO Search Process
- Clorox to Present at dbAccess Global Consumer Conference
- Clorox Company filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Hidden Valley™ Ranch Expands into Protein-Forward Snacking with New Line of Seasoned Chicken Dippers
- SEC Form FWP filed by Clorox Company
- SEC Form 424B3 filed by Clorox Company
- Director Breber Pierre R bought $429,124 worth of shares (5,000 units at $85.82) (SEC Form 4)